Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
Journal: International journal of radiation oncology, biology, physics
Published: June 16, 2023
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003.
Journal: Advances in radiation oncology
Published: September 11, 2022
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Journal: Advances in radiation oncology
Published: August 02, 2022
Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone.
Journal: Frontiers in oncology
Published: April 21, 2022
Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose.
Journal: Journal of cancer therapy
Published: November 22, 2021
Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry.
Journal: Journal of patient-reported outcomes
Published: August 10, 2021
Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy.
Journal: Radiation oncology journal
Published: March 31, 2021
Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer.
Journal: International journal of particle therapy
Published: February 09, 2021
Unplanned implant removal in locally advanced breast cancer.
Journal: The breast journal
Published: December 09, 2020
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
Journal: Cancer
Published: June 10, 2020
Last Updated: 09/26/2026